Khashayar Mozaffari1, Laurence Davidson2, Eric Chalif3, Tiffany N Phan2, Andrew D Sparks4, John S Myseros2, Chima O Oluigbo2, Robert F Keating2. 1. George Washington University School of Medicine and Health Sciences, Washington, DC, USA. kmozaffari@gwmail.gwu.edu. 2. Division of Neurosurgery, Children's National Hospital, Washington, DC, USA. 3. George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 4. Department of Surgery, The George Washington University Hospital, Washington, DC, USA.
Abstract
PURPOSE: The role of an osseous-only posterior fossa decompression (PFD) for Chiari malformation type 1 (CM1) remains controversial. We reviewed long-term outcomes for patients with CM1 undergoing a PFD to evaluate if there was any difference for failure when compared to patients undergoing a PFD with duraplasty (PFDD). METHODS: Consecutive patients surgically treated at a single tertiary pediatric neurosurgery clinic over a 25-year period with at least 5 years of follow-up were evaluated. PFD patients were compared to those that initially received a PFDD. Demographics, surgical indications, surgical approach, outcomes, and complications were reviewed. RESULTS: A total of 60 patients were included in this study of which 25 (41.67%) underwent PFD and 35 (58.33%) underwent PFDD. Mean age at surgery was 7.41 years (range 0.4 to 18 years) with a mean follow-up of 8.23 years (range 5 to 21 years). Those that received a PFD had a lower rate of radiographic syrinx improvement (p = 0.03), especially in the setting of holocord syringes. Failure rate was significantly higher in the PFD group (20% vs 2.90%, p = 0.03). However, complications were significantly higher in the PFDD group (17.14% vs 4.0%, p = 0.04). CONCLUSIONS: PFD provides a safe treatment option with similar clinical improvements and lower post-operative complication rate compared to PFDD, albeit at the cost of greater chance of reoperation, especially in the setting of a holocord syrinx. Patients with a holocord syrinx should be considered for a PFDD as their initial procedure.
PURPOSE: The role of an osseous-only posterior fossa decompression (PFD) for Chiari malformation type 1 (CM1) remains controversial. We reviewed long-term outcomes for patients with CM1 undergoing a PFD to evaluate if there was any difference for failure when compared to patients undergoing a PFD with duraplasty (PFDD). METHODS: Consecutive patients surgically treated at a single tertiary pediatric neurosurgery clinic over a 25-year period with at least 5 years of follow-up were evaluated. PFD patients were compared to those that initially received a PFDD. Demographics, surgical indications, surgical approach, outcomes, and complications were reviewed. RESULTS: A total of 60 patients were included in this study of which 25 (41.67%) underwent PFD and 35 (58.33%) underwent PFDD. Mean age at surgery was 7.41 years (range 0.4 to 18 years) with a mean follow-up of 8.23 years (range 5 to 21 years). Those that received a PFD had a lower rate of radiographic syrinx improvement (p = 0.03), especially in the setting of holocord syringes. Failure rate was significantly higher in the PFD group (20% vs 2.90%, p = 0.03). However, complications were significantly higher in the PFDD group (17.14% vs 4.0%, p = 0.04). CONCLUSIONS: PFD provides a safe treatment option with similar clinical improvements and lower post-operative complication rate compared to PFDD, albeit at the cost of greater chance of reoperation, especially in the setting of a holocord syrinx. Patients with a holocord syrinx should be considered for a PFDD as their initial procedure.
Authors: Meike W Vernooij; M Arfan Ikram; Hervé L Tanghe; Arnaud J P E Vincent; Albert Hofman; Gabriel P Krestin; Wiro J Niessen; Monique M B Breteler; Aad van der Lugt Journal: N Engl J Med Date: 2007-11-01 Impact factor: 91.245
Authors: R Shane Tubbs; Joshua Beckman; Robert P Naftel; Joshua J Chern; John C Wellons; Curtis J Rozzelle; Jeffrey P Blount; W Jerry Oakes Journal: J Neurosurg Pediatr Date: 2011-03 Impact factor: 2.375
Authors: Jennifer Strahle; Karin M Muraszko; Joseph Kapurch; J Rajiv Bapuraj; Hugh J L Garton; Cormac O Maher Journal: J Neurosurg Pediatr Date: 2011-08 Impact factor: 2.375
Authors: Leslie A Aitken; Camilla E Lindan; Stephen Sidney; Nalin Gupta; A James Barkovich; Michael Sorel; Yvonne W Wu Journal: Pediatr Neurol Date: 2009-06 Impact factor: 3.372
Authors: Omar F Jbarah; Bahaa I Aburayya; Ayman R Shatnawi; Mohab A Alkhasoneh; Ahmad A Toubasi; Sondos M Alharahsheh; Saleem K Nukho; Asil S Nassar; Mohammad A Jamous Journal: Neurosurg Rev Date: 2022-10-01 Impact factor: 2.800